efonidipine has been researched along with Atrial Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitamura, H; Ogawa, S; Ohashi, N | 1 |
| Fukuda, Y; Hara, M; Kinebuchi, O; Kurita, Y; Mitamura, H; Miyoshi, S; Ogawa, S; Ohashi, N; Shiroshita-Takeshita, A; Takatsuki, S; Tanimoto, K | 1 |
1 review(s) available for efonidipine and Atrial Fibrillation
| Article | Year |
|---|---|
Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Drug Delivery Systems; Humans; Nitrophenols; Organophosphorus Compounds | 2009 |
1 other study(ies) available for efonidipine and Atrial Fibrillation
| Article | Year |
|---|---|
A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling.
Topics: Administration, Oral; Animals; Atrial Fibrillation; Atrioventricular Node; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiac Pacing, Artificial; Dihydropyridines; Dogs; Electrophysiology; Forecasting; Heart Atria; Japan; Male; Nitrophenols; Organophosphorus Compounds; Refractory Period, Electrophysiological; Research Design; Time Factors; Verapamil | 2004 |